• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Association between acneiform eruption grade and survival outcomes in EGFRi-treated metastatic colorectal cancer patients: A retrospective cohort study.

作者信息

Ong Michael M, Dusza Stephen W, Sugarman Ryan, Kazi Rashek

机构信息

Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

出版信息

J Am Acad Dermatol. 2025 Sep 15. doi: 10.1016/j.jaad.2025.07.076.

DOI:10.1016/j.jaad.2025.07.076
PMID:40962191
Abstract
摘要

相似文献

1
Association between acneiform eruption grade and survival outcomes in EGFRi-treated metastatic colorectal cancer patients: A retrospective cohort study.表皮生长因子受体抑制剂治疗的转移性结直肠癌患者中，痤疮样皮疹分级与生存结果的关联：一项回顾性队列研究。
J Am Acad Dermatol. 2025 Sep 15. doi: 10.1016/j.jaad.2025.07.076.
2
Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal Cancer.探索西妥昔单抗与帕尼单抗作为一线表皮生长因子受体（EGFR）抑制剂用于左侧、RAS野生型转移性结直肠癌患者的真实世界疗效。
Clin Colorectal Cancer. 2025 Sep;24(3):362-368. doi: 10.1016/j.clcc.2025.04.001. Epub 2025 Apr 30.
3
The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model.西妥昔单抗（单药或联合化疗）、贝伐珠单抗（联合非奥沙利铂化疗）和帕尼单抗（单药治疗）用于一线化疗后转移性结直肠癌治疗的临床疗效和成本效果评价（技术评估 150 号报告的部分回顾和技术评估 118 号报告的综述）：系统评价和经济模型。
Health Technol Assess. 2013 Apr;17(14):1-237. doi: 10.3310/hta17140.
4
An Analysis of Risk Factors for the Development of Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors.分析单克隆抗体表皮生长因子受体抑制剂治疗患者痤疮样疹发生的危险因素。
J Cutan Med Surg. 2023 Nov;27(6):614-620. doi: 10.1177/12034754231211326. Epub 2023 Nov 9.
5
A systematic review of oral retinoids for treatment of acneiform eruptions induced by epidermal growth factor receptor inhibitors.表皮生长因子受体抑制剂诱导的痤疮样发疹的口服维甲酸治疗的系统评价。
Dermatol Ther. 2022 May;35(5):e15412. doi: 10.1111/dth.15412. Epub 2022 Mar 3.
6
The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.西妥昔单抗（技术评估报告第176号综述）和帕尼单抗（技术评估报告第240号部分综述）用于既往未治疗的转移性结直肠癌的临床疗效和成本效果：一项系统评价与经济学评估
Health Technol Assess. 2017 Jun;21(38):1-294. doi: 10.3310/hta21380.
7
Acneiform eruptions with combination targeted cancer therapy in colorectal cancer patients.结直肠癌患者接受联合靶向癌症治疗后出现痤疮样皮疹。
Support Care Cancer. 2022 Oct;30(10):8051-8058. doi: 10.1007/s00520-022-07257-2. Epub 2022 Jun 30.
8
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer.用于转移性结直肠癌的表皮生长因子受体（EGFR）抑制剂
Cochrane Database Syst Rev. 2017 Jun 27;6(6):CD007047. doi: 10.1002/14651858.CD007047.pub2.
9
EGFRI-associated health-related quality of life by severity of skin toxicity in metastatic colorectal cancer patients receiving epidermal growth factor receptor inhibitor target therapy.表皮生长因子受体抑制剂靶向治疗转移性结直肠癌患者皮肤毒性严重程度与健康相关生活质量的关系。
Support Care Cancer. 2020 Oct;28(10):4771-4779. doi: 10.1007/s00520-020-05321-3. Epub 2020 Jan 23.
10
Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induced by cetuximab and panitumumab: A multicenter, phase II trial.西妥昔单抗和帕尼单抗诱导的痤疮样皮疹应用局部过氧化苯甲酰的疗效和安全性：一项多中心、Ⅱ期临床试验。
J Dermatol. 2021 Jul;48(7):1077-1080. doi: 10.1111/1346-8138.15836. Epub 2021 Mar 8.

引用本文的文献

1
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.口服米诺地尔治疗脱发：风险、益处及建议。
Am J Clin Dermatol. 2025 Oct 21. doi: 10.1007/s40257-025-00990-4.